Currently out of the existing stock ratings of Lawrence Keusch, 19 are a HOLD (14.5%), 110 are a BUY (83.97%), 2 are a SELL (1.53%).

Lawrence Keusch

Work Performance Price Targets & Ratings Chart

Analyst Lawrence Keusch, carries an average stock price target met ratio of 74.95% that have a potential upside of 19.78% achieved within 244 days. Previously, Lawrence Keusch worked at WELLS FARGO, RAYMOND JAMES.

Lawrence Keusch’s has documented 260 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 11-Feb-2026.

Wall Street Analyst Lawrence Keusch

Analyst best performing recommendations are on AVTR (AVANTOR).
The best stock recommendation documented was for HAE (HAEMONETICS) at 8/5/2020. The price target of $93 was fulfilled within 35 days with a profit of $16.89 (22.19%) receiving and performance score of 6.34.

Average potential price target upside

of $69.31 (22.4%) on TFX (TELEFLEX).
of $35.94 (18.81%) on SYK (STRYKER).
of $28.36 (13.09%) on ISRG (INTUITIVE SURGICAL).

AVNS Avanos Medical AVTR Avantor BAX Baxter International BDX Becton Dickinson and Company COO The Cooper Companies Common Stock HAE Haemonetics HRC Hill-Rom Holdings ISRG Intuitive Surgical MASI Masimo SYK Stryker TFX Teleflex ZBH Zimmer Biomet Holdings CMD Cantel Medical Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Rick Wise (STIFEL)